                         SEQUENCE LISTING

<110>  Epitomics Inc
 
<120>  HIGH THROUGHPUT MONOCLONAL ANTIBODY GENERATION BY

<130>  EPIT-046WO

<150>  62/135,084
<151>  2015-03-18

<160>  7     

<170>  PatentIn version 3.5

<210>  1
<211>  61
<212>  DNA
<213>  Artificial sequence

<220>
<223>  Synthetic oligonucleotide

<400>  1
tcgtcggcag cgtcagatgt gtataagaga cagatggaga ctgggctgcg ctggcttctc       60

c                                                                       61


<210>  2
<211>  60
<212>  DNA
<213>  Artificial sequence

<220>
<223>  Synthetic oligonucleotide

<400>  2
gtctcgtggg ctcggagatg tgtataagag acagcagtgg gaagactgac ggagccttag       60


<210>  3
<211>  59
<212>  DNA
<213>  Artifical sequence

<400>  3
gtctcgtggg ctcggagatg tgtataagag acagcagtgg gaagactgat ggagcctta        59


<210>  4
<211>  53
<212>  DNA
<213>  Artificial sequence

<220>
<223>  Synthetic oligonucleotide

<400>  4
tcgtcggcag cgtcagatgt gtataagaga cagatggaca cgagggcccc cac              53


<210>  5
<211>  58
<212>  DNA
<213>  Artificial sequence

<220>
<223>  Synthetic oligonucleotide

<400>  5
gtctcgtggg ctcggagatg tgtataagag acagtggtgg gaagakgagg acagtagg         58


<210>  6
<211>  58
<212>  DNA
<213>  Artificial sequence

<220>
<223>  Synthetic oligonucleotide

<400>  6
gtctcgtggg ctcggagatg tgtataagag acagtggtgg gaagakgagg acactagg         58


<210>  7
<211>  58
<212>  DNA
<213>  Artificial sequence

<220>
<223>  Synthetic oligonucleotide

<400>  7
gtctcgtggg ctcggagatg tgtataagag acagtggtgg gaagakgagg acagaagg         58


